Programming of hypertension associations of plasma aldosterone in adult men and women with birthweight, cortisol, and blood pressure

Hypertension

Volumn 53, Issue 6, 2009, Pages 932-936

  Reynolds, Rebecca M ^a   Walker, Brian R ^a   Phillips, David I ^b   Dennison, Elaine M ^b   Fraser, Robert ^c   Mackenzie, Scott M ^c   Davies, Eleanor ^c   Connell, John M ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Aldosterone; Glucocorticoid; Hypertension; Mineralocorticoid; Programming

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; DIAGNOSTIC AGENT;

AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC CODE; GENOTYPE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; AGE; ANALYSIS OF VARIANCE; BIRTH WEIGHT; BLOOD; BLOOD PRESSURE MEASUREMENT; COHORT ANALYSIS; COMPARATIVE STUDY; HYPOPHYSIS ADRENAL SYSTEM; METABOLISM; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PROBABILITY; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL;

ADRENOCORTICOTROPIC HORMONE; AGE FACTORS; AGED; ALDOSTERONE; ANALYSIS OF VARIANCE; BIRTH WEIGHT; BLOOD PRESSURE DETERMINATION; COHORT STUDIES; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; HYPERTENSION; LINEAR MODELS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PITUITARY-ADRENAL SYSTEM; PROBABILITY; RISK FACTORS; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 67049117543     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.129320     Document Type: Article

References (34)

1. Barker DJP, Osmond C, Golding J, Kuh D, Wadsworth MET. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Brit Med J. 1989;298:564-567.
2. Seckl JR. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol. 2004:151:49-62.
3. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CRW. Glu-cocorticoid exposure in utero: new model for adult hypertension. Lancet. 1993:341:339-341.
4. Levitt NS, Holmes MC, Lindsay RS, Seckl JR. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology. 1996;64:412-418.
5. Phillips DIW, Barker DJP, Fall CHD, Whorwood CB, Seckl JR, Wood PJ, Walker BR. Elevated plasma cortisol concentrations: an explanation for the relationship between low birthweight and adult cardiovascular risk factors. J Clin Endocrinol Metab. 1998;83:757-760.
6. Phillips DIW, Walker BR, Reynolds RM, Flanagan DEH, Wood PJ, Osmond C, Barker DJP, Whorwood CB. Low birthweight and elevated plasma cortisol concentrations in adults from three populations. Hypertension. 2000;35:1301-1306.
7. Reynolds RM, Walker BR, Phillips DIW, Sydall HE, Andrew R, Wood PJ, Whorwood CB. Altered control of cortisol secretion in adult men with low birthweight and cardiovascular risk factors. J Clin Endocrinol Metab. 2001;86:245-250.
8. Reynolds RM, Walker BR, Syddall HE, Andrew R, Wood PJ, Phillips DIW. Is there a gender difference in the associations of low birthweight with adult hypothalamic-pituitary-adrenal axis activity? Eur J Endocrinol. 2005:152:249-253.
9. Freel EM, Ingram M, Wallace AM, White A, Fraser R, Davies E, Connell JM. Effect of variation in CYP11B1 and CYP11B2 on corticosteroid phenotype and hypothalamic-pituitary-adrenal axis activity in hypertensive and normotensive subjects. Clin Endocrinol (Oxf). 2008;68: 700-706.
10. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med. 2004;351:33-41.
11. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol. 1994;21:315-318.
12. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet. 1999;353:40.
13. Olivieri O, Ciacciarelli A, Signorelli D, Pizzolo F, Guarini P, Pavan C, Corgnati A, Falcone S, Corrocher R, Micchi A, Cressoni C, Blengio G. Aldosterone to renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab. 2004;89:4221-42226.
14. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293-2300.
15. Kaplan NM. Deja vu for primary aldosteronism. Lancet. 2008;371: 1890-1891.
16. O'Regan D, Kenyon CJ, Seckl JR, Holmes MC. Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology. Am J Physiol. 2004;287:E863-E870.
17. Grigore D, Ojeda NB, Robertson EB, Dawson AS, Huffman CA, Bourassa EA, Speth RC, Brosnihan KB, Alexander BT. Placental insufficiency results in temporal alterations in the renin angiotensin system in male hypertensive growth restricted offspring. Am J Physiol. 2007;293: R804-R811.
18. Fall CHD, Osmond C, Barker DJP, Clark PMS, Hales CN, Stirling Y. Fetal and infant growth and cardiovascular risk factors in women. BMJ. 1995:310:428-431.
19. Hales CN, Barker DJP, Clark PMS, Cox CJ, Fall C, Osmond C. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991;303: 1019-1022.
20. Daidoh H, Morita H, Mune T, Murayama M, Hanafusa J, Ni H, Shibata H, Yasuda K. Responses of plasma adrenocortical steroids to low dose ACTH in normal subjects. Clin Endocrinol. 1995;43:311-315.
21. Walker BR, Best R, Shackleton CHL, Padfield PL, Edwards CRW. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension. 1996:27:190-196.
22. Bender JW, Davitt MK, Jose P. Angiotensin I-converting enzyme activity in term and premature infants. Biol Neonate. 1978;34:19-23.
23. Miyawaki M, Okutani T, Higuchl R, Yoshikawa N. Plasma angiotensin II concentrations in the early neonatal period. Arch Dis Child Fetal Neonatal Ed. 2006;91:F359-F362.
24. Forsyth JS, Reilly J, Fraser CG, Struthers AD. Angiotensin converting enzyme activity in infancy is related to birth weight. Arch Dis Child Fetal Neonatal Ed. 2004;89:F442-F444.
25. Franco MC, Casarini DE, Cameiro-Ramos MS, Sawaya AL, Barreto-Chaves ML, Sesso R. Circulating renin-angiotensin system and catechol-amines in childhood: is there a role for birthweight? Clin Sci (Lond). 2008:114:375-380.
26. Akisu M, Balim Z, Cetin H, Kosova B, Yalaz M, Topcuoglu N, Kultursay N. The role of angiotensin-converting enzyme and apolipoprotein-E gene polymorphisms on lipid compositions in newborn infants with intra-uterine growth restriction. Early Hum Dev. 2004;78:95-103.
27. Cambien F, Leger J, Mallet C, Levy-Marchal C, Collin D, Czernichow P. Angiotensin I-converting enzyme gene polymorphism modulates the consequences of in utero growth retardation on plasma insulin in young adults. Diabetes. 1998;47:470-475.
28. Kajantie E, Rautanen A, Kere J, Andersson S, Yliharsila H, Osmond C, Barker DJ, Forsen T, Eriksson J. The effects of the ACE gene insertion/ deletion polymorphism on glucose tolerance and insulin secretion in elderly people are modified by birth weight. J Clin Endocrinol Metab. 2004;89:5738-5741.
29. Marin P, Darin M, Amemiya T, Andersson B, Jem S, Bjorntorp P. Cortisol secretion in relation to body fat distribution in obese Premenopausal women. Metabolism. 1992;41:882-886.
30. Strain GW, Zumoff B, Kream J, Strain JJ, Levin J, Fukushima D. Sex difference in the influence of obesity on the 24 hour mean plasma concentration of cortisol. Metabolism. 1982;31:209-212.
31. Connell JM, Mackenzie SM, Freel EM, Fraser R, Davies E. A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev. 2008;29: 133-154.
32. Christy NP, Laragh JH. Pathogenesis of hypokalemic alkalosis in Cushing's syndrome. N Engl J Med. 1961;265:1083-1088.
33. Richards AM, Nicholls MG, Espiner EA, Ikram H, Cullens M, Hinton D. Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clin Exp Hypertens A. 1986;8:153-166.
34. Freel EM, Ingram M, Friel EC, Fraser R, Brown M, Samani NJ, Caulfield M, Munroe P, Farrall M, Webster J, Clayton D, Dominiczak AF, Davies E, Connell JM. Phenotypic consequences of variation across the aldosterone synthase and 11-beta hydroxylase locus in a hypertensive cohort: data from the MRC BRIGHT Study. Clin Endocrinol (Oxf). 2007;67: 832-838.